Pharma sits on a ton of data. Its infrastructure doesn't quite keep up
The pharma industry has hurried to adapt to the critical changes of the digital age — right as Amazon and Apple increased their interest in the healthcare sector.
Motivation to deploy robust digital strategies comes by way of new revenue streams made possible by technology. Researchers from Russell Reynolds Associates identify digital therapeutics, AI-driven drug discovery and virtual healthcare as emerging fields for additional revenue streams.
But for global pharma companies, the abundance and diversity of data inputs could actually work to their disadvantage, as the correct infrastructure to process them isn't yet in place.
To read the full article, click here.